EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drugs acting at TRPM7 channels inhibit seizure‐like activity

Aytakin Khalil, Tawfeeq Shekh-Ahmad iD, Stjepana Kovac, Robert C Wykes iD, F David Horgen, Andrea Fleig, Matthew C Walker iD

Epilepsia Open · 2023

DOI: 10.1002/epi4.12773 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia Open, 2023. Verfasst von Aytakin Khalil und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London, UK. Hauptthemen laut MEDLINE: TRPM Cation Channels, Seizures, Pentylenetetrazole, Cymenes. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transient receptor potential cation subfamily M7 (TRPM7) channels are ion channels permeable to divalent cations. They are abundantly expressed with particularly high expression in the brain. Previous studies have highlighted the importance of TRPM7 channels in brain diseases such as stroke and traumatic brain injury, yet evidence for a role in seizures and epilepsy is lacking. Here, we show that carvacrol, a food additive that inhibits TRPM7 channels, and waixenicin A, a novel selective and potent TRPM7 inhibitor, completely suppressed seizure‐like activity in rodent hippocampal‐entorhinal brain slices exposed to pentylenetetrazole or low magnesium. These findings support inhibition of TRPM7 channels as a novel target for antiseizure medications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TRPM Cation ChannelsSeizuresPentylenetetrazoleCymenesAnimalsAnticonvulsantsMiceHippocampusRatsMaleDisease Models, AnimalAcetatesDiterpenes

Stichwörter der Autor:innen

TRPM7carvacrolepilepsyseizurewaixenicin A

Substanzen

TRPM Cation ChannelsPentylenetetrazolecarvacrolCymeneswaixenicin AAnticonvulsantsTrpm7 protein, mouseAcetatesDiterpenes

Autor:innen und Institutionen

  • Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • The Institute for Drug Research, The School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Department of Neurology, University of Münster, Münster, Germany.
  • Nanomedicine Lab, Division of Neuroscience, University of Manchester, Manchester, UK.
  • Department of Natural Sciences, Hawaii Pacific University, Kaneohe, Hawaii, USA.
  • The Queen's Medical Center and John A. Burns School of Medicine and Cancer Center, University of Hawaii, Honolulu, Hawaii, USA.

ORCID-Profile: Tawfeeq Shekh-Ahmad, Robert C Wykes, Matthew C Walker

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Khalil, A., Shekh-Ahmad, T., Kovac, S., Wykes, R. C., Horgen, F. D., Fleig, A., & Walker, M. C. (2023). Drugs acting at TRPM7 channels inhibit seizure‐like activity. Epilepsia Open. https://doi.org/10.1002/epi4.12773

Vancouver

Khalil A, Shekh-Ahmad T, Kovac S, Wykes RC, Horgen FD, Fleig A, et al. Drugs acting at TRPM7 channels inhibit seizure‐like activity. Epilepsia Open. 2023. doi:10.1002/epi4.12773

BibTeX
@article{Khalil2023,
  author = {Khalil, Aytakin and Shekh-Ahmad, Tawfeeq and Kovac, Stjepana and Wykes, Robert C and Horgen, F David and Fleig, Andrea and Walker, Matthew C},
  title = {Drugs acting at TRPM7 channels inhibit seizure‐like activity},
  journal = {Epilepsia Open},
  year = {2023},
  doi = {10.1002/epi4.12773}
}
Kostenlos starten →